- Home
- MDGL vs FCFS Comparison
MDGL vs FCFS Comparison
Compare MDGL & FCFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDGL | FCFS |
|---|---|---|
| Founded | 2011 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5B | 7.2B |
| IPO Year | N/A | 1991 |
Fundamental Metrics
Financial Performance| Metric | MDGL | FCFS |
|---|---|---|
| Price | $602.82 | $162.35 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 4 |
| Target Price | ★ $580.77 | $168.75 |
| AVG Volume (30 Days) | ★ 285.6K | 231.9K |
| Earning Date | 11-04-2025 | 01-29-2026 |
| Dividend Yield | N/A | ★ 1.03% |
| EPS Growth | N/A | ★ 27.90 |
| EPS | N/A | ★ 6.92 |
| Revenue | $740,640,000.00 | ★ $3,486,435,000.00 |
| Revenue This Year | $435.63 | $8.28 |
| Revenue Next Year | $52.56 | $10.44 |
| P/E Ratio | ★ N/A | $23.45 |
| Revenue Growth | ★ 864.21 | 3.86 |
| 52 Week Low | $265.00 | $101.75 |
| 52 Week High | $615.00 | $166.08 |
Technical Indicators
Market Signals| Indicator | MDGL | FCFS |
|---|---|---|
| Relative Strength Index (RSI) | 65.63 | 55.49 |
| Support Level | $535.33 | $160.12 |
| Resistance Level | $609.98 | $163.63 |
| Average True Range (ATR) | 20.31 | 3.70 |
| MACD | 0.28 | 0.08 |
| Stochastic Oscillator | 84.71 | 74.92 |
Price Performance
Historical ComparisonAbout MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About FCFS FirstCash Holdings Inc.
FirstCash Holdings Inc operates pawn stores in the United States and Latin America. Its primary business involves making small loans secured by personal property. The the company has three reportable segments: U.S. pawn; Latin America pawn; and Retail POS payment solutions (AFF). It derives majority revenue from U.S. Pawn segment. These pawn loans give the borrower the option of either repaying the loans with interest or forfeiting the property without further penalty. Geographically operates in USA, Mexico, Latin America, with maximum revenue from USA.